Company intelligence / Profile preview

Enamine

Ownership: Private
Employees: ~2000
Development stage: Commercial

Overview

Enamine does not have its own clinical pipeline or results. It supplies chemical compounds and R&D services to pharmaceutical, biotech companies, academic institutions, and research organizations globally.

Modalities: Small moleculeFragments (as part of fragment-based drug discovery)Building blocks for medicinal chemistry
Industry: Drug Discovery Services

Partnerships

Pfizer – access to selected reference compounds for global researchersPohang Accelerator Laboratory – collaboration on fragment-based drug discovery projects

Beyond the preview

Go deeper on Enamine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enamine.

Explore the full profile